Intuitive Surgical, Inc. $ISRG Shares Purchased by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,500 shares of the medical equipment provider’s stock after buying an additional 2,422 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Intuitive Surgical were worth $8,743,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Ritholtz Wealth Management grew its holdings in shares of Intuitive Surgical by 9.9% during the 3rd quarter. Ritholtz Wealth Management now owns 6,361 shares of the medical equipment provider’s stock worth $2,587,000 after acquiring an additional 571 shares during the period. UNIVEST FINANCIAL Corp lifted its stake in shares of Intuitive Surgical by 16.1% in the 3rd quarter. UNIVEST FINANCIAL Corp now owns 13,113 shares of the medical equipment provider’s stock valued at $5,332,000 after purchasing an additional 1,822 shares during the period. Joel Isaacson & Co. LLC lifted its stake in shares of Intuitive Surgical by 7.6% in the 3rd quarter. Joel Isaacson & Co. LLC now owns 2,853 shares of the medical equipment provider’s stock valued at $1,160,000 after purchasing an additional 201 shares during the period. Jacobi Capital Management LLC lifted its stake in shares of Intuitive Surgical by 52.1% in the 3rd quarter. Jacobi Capital Management LLC now owns 2,062 shares of the medical equipment provider’s stock valued at $838,000 after purchasing an additional 706 shares during the period. Finally, First Command Advisory Services Inc. boosted its position in shares of Intuitive Surgical by 48.4% during the third quarter. First Command Advisory Services Inc. now owns 552 shares of the medical equipment provider’s stock valued at $224,000 after purchasing an additional 180 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on ISRG. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a report on Wednesday, October 21st. Finally, Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Stock Performance

ISRG stock opened at $439.89 on Friday. The firm has a 50 day moving average price of $416.12 and a 200-day moving average price of $430.38. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The firm has a market capitalization of $152.48 billion, a price-to-earnings ratio of 53.19, a PEG ratio of 3.10 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the business posted $2.40 EPS. The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the completion of the transaction, the director directly owned 1,194,530 shares in the company, valued at $546,306,350.20. This trade represents a 0.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the transaction, the director directly owned 1,150 shares of the company’s stock, valued at approximately $529,000. This represents a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 39,456 shares of company stock valued at $17,769,124. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.